Common causes and current guidelines

Chronic Respiratory Disease

Volumn 4, Issue 4, 2007, Pages 215-223

  McGarvey, Lorcan P A ^a,b   Polley, L ^a   MacMahon, J ^a,b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Aetiology; Cough; Guidelines; Treatment

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; PROTON PUMP INHIBITOR;

ASTHMA; BRONCHITIS; CLINICAL TRIAL; COUGHING; GASTROESOPHAGEAL REFLUX; HUMAN; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY;

ALGORITHMS; ASTHMA; BRONCHITIS; CHRONIC DISEASE; CLINICAL PROTOCOLS; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 38049095611     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972307084447     Document Type: Review

References (82)

1. Morice AH, Fontana GA, Sovijarvi AR et al. The diagnosis and management of chronic cough. Eur Respir J 2004; 24(3): 481-92.
2. Irwin RS. Introduction to the diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl 1): 25S-27.
3. Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax 2006; 61(Suppl 1): i1-24.
4. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318(7182): 527-30.
5. Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110(6): 451-7.
6. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis 2001; 32(5): 728-41.
7. Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006; 130(3): 794-9.
8. Dheda K, Crawford A, Hagan G, Roberts CM. Implementation of British thoracic society guidelines for acute exacerbation of chronic obstructive pulmonary disease: impact on quality of life. Postgrad Med J 2004; 80(941): 169-71.
9. Barlow G, Nathwani D, Williams F et al. Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis. Thorax 2007; 62(1): 67-74.
10. Guest JF, Varney SJ, Diggle J. Impact of the British thoracic society chronic obstructive pulmonary disease guidelines on patients' health status, healthcare resource use and health-related quality of life. Prim Care Respir J 2005; 14(5): 242-51.
11. Committee for the Japanese Respiratory Society Guidelines for Management of Cough, Kohno S, Ishida T et al. The Japanese respiratory society guidelines for management of cough. Respirology 2006; 11(Suppl 4): S135-86.
12. Plaza V, Miguel E, Bellido-Casado J, Lorano MP, Rios L, Bolibar I. Usefulness of the guidelines of the Spanish society of pulmonology and thoracic surgery (SEPAR) in identifying the causes of chronic cough. Arch Bronconeumol 2006; 42(2): 68-73.
13. Hampton T. New guidelines released for managing cough. JAMA 2006; 295(7): 746-7.
14. Cough guidelines choke on evidence. Lancet 2006; 367(9507): 276.
15. Niimi A. Geography and cough aetiology. Pulm Pharmacol Ther 2007; 62(6): 491-5.
16. Chung KF, McGarvey L, Widdicombe J. American college of chest physicians' cough guidelines. Lancet 2006; 367(9515): 981-2.
17. Glauser FL. Variant asthma. Ann Allergy 1972; 30(8): 457-9.
18. McGarvey LP, Heaney LG, Lawson JT et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53(9): 738-43.
19. Fujimura M, Nishizawa Y, Nishitsuji M, Abo M, Kita T, Nomura S. Longitudinal decline in pulmonary function in atopic cough and cough variant asthma. Clin Exp Allergy 2003; 33(5): 588-94.
20. Todokoro M, Mochizuki H, Tokuyama K, Morikawa A. Childhood cough variant asthma and its relationship to classic asthma. Ann Allergy Asthma Immunol 2003; 90(6): 652-9.
21. Matsumoto H, Niimi A, Takemura M et al. Prognosis of cough variant asthma: a retrospective analysis. J Asthma 2006; 43(2): 131-5.
22. Fujimura M, Hara J, Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005; 1: 5.
23. Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(1 Suppl): 75S-9.
24. Brightling CE, Pavord ID. Eosinophilic bronchitis: an important cause of prolonged cough. Ann Med 2000; 32(7): 446-51.
25. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346(22): 1699-705.
26. Park SW, Lee YM, Jang AS et al. Development of chronic airway-obstruction in patients with eosinophilic bronchitis: a prospective follow-up study. Chest 2004; 125(6): 1998-2004.
27. Birring SS, Berry M, Brightling CE, Pavord ID. Eosinophilic bronchitis: clinical features, management and pathogenesis. Am J Respir Med 2003; 2(2): 169-73.
28. McGarvey L, Morice AH. Atopic cough: little evidence to support a new clinical entity. Thorax 2003; 58(8): 736-7 (author reply 737-8).
29. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl 1): 63S-71.
30. Irwin RS, Curley FJ, French CL. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141(3): 640-7.
31. O'Hara J, Jones NS. 'Post-nasal drip syndrome': most patients with purulent nasal secretions do not complain of chronic cough. Rhinology 2006; 44(4): 270-3.
32. O'Hara J, Jones NS. The aetiology of chronic cough: a review of current theories for the otorhinolaryngologist. J Laryngol Otol 2005; 119(7): 507-14.
33. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl 1): 63S-71.
34. Bel A, Labarre JF, Thivolle P, Passot E. Broncho-pulmonary manifestations and gastroesophageal reflux. Poumon Coeur 1977; 33(6): 345-50.
35. Euler AR, Byrne WJ, Ament ME et al. Recurrent pulmonary disease in children: a complication of gastroesophageal reflux. Pediatrics 1979; 63(1):47-51.
36. Ford AC, Forman D, Moayyedi P, Morice AH. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006; 61(11): 975-9.
37. Franco RA, Jr. Laryngopharyngeal reflux. Allergy Asthma Proc 2006; 27(1): 21-5.
38. Nordenstedt H, Nilsson M, Johansson S et al. The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest 2006; 129(4): 1051-6.
39. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101(8): 1900-20 (quiz 1943).
40. Phua SY, McGarvey LP, Ngu MC, Ing AJ. Patients with gastrooesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity. Thorax 2005; 60(6): 488-91.
41. Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 1994; 149(1): 160-7.
42. Patterson RN, Johnston BT, Ardill JE, Heaney LG, McGarvey LP. Elevated tachykinin levels in induced sputum from asthmatics and cough patients with acid reflux. Thorax 2007; 62(6): 491-5.
43. Chang AB, Gibson PG, Ardill J, McGarvey LP. Calcitonin gene-related peptide relates with cough sensitivity in children with chronic cough. Eur Respir J 2007; 30(1): 66-72.
44. Kastelik JA, Redington AE, Aziz I et al. Abnormal oesophageal motility in patients with chronic cough. Thorax 2003; 58(8): 699-702.
45. Patterson RN, Johnston BT, MacMahon J, Heaney LG, McGarvey LP. Oesophageal pH monitoring is of limited value in the diagnosis of 'reflux-cough'. Eur Respir J 2004; 24(5): 724-7.
46. Chang AB, Lasserson TJ, Kiljander TO, Connor FL, Gaffney JT, Garske LA. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic-cough associated with gastro-oesophageal reflux. BMJ 2006; 332(7532): 11-7.
47. Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastrooesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Datahase Syst Rev 2006; (4): CD004823.
48. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-8.
49. Kiljander TO, Salomaa ER, Hietanen EK, Terho EO. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole, (abstract). Eur Respir J 2000; 16: 633-8.
50. Irwin RS. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl 1): 80S-94.
51. Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2005; 54(4): 449-54.
52. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006: 55(10): 1398-402.
53. Bredenoord AJ, Tutuian R, Smout AJ, Castell DO. Technology Review: Esophageal Impedance Monitoring. Am J Gastroenterol 2007; 101(11): 2470-5.
54. Swoger J, Ponsky J, Hicks DM et al. Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol 2006; 4(4): 433-41.
55. Kaufman JA, Houghland JE, Quiroga E, Cahill M, Pellegrini CA, Oelschlager BK. Long-term outcomes of laparoscopic anti-reflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc 2006; 20(12): 1824-30.
56. Khan AM, Hashmi SR, Elahi F, Tariq M, Ingrams DR. Laryngopharyngeal reflux: a literature review. Surgeon 2006; 4(4): 221-5.
57. Polley L, Cardwell C, Costello R, McGarvey L. Predictors of idiopathic cough: outcome of a retrospective analysis, (abstract). Thorax 2005; 60: 107.
58. Haque RA, Usmani OS, Barnes PJ. Chronic idiopathic cough: a discrete clinical entity? Chest 2005; 127(5): 1710-3.
59. McGarvey LP. Idiopathic chronic cough: a real disease or a failure of diagnosis? Cough 2005; 1: 9.
60. McGarvey LP, Ing AJ. Idiopathic cough, prevalence and underlying mechanisms. Pulm Pharmacol Ther 2004; 17(6): 435-9.
61. Davenport PW, Boiser DC, Vickroy T et al. The effect of codeine on the urge-to-cough response to inhaled capsaicin. Pulm Pharmacol Ther 2007; 20(4): 338-46.
62. Canning BJ. Anatomy and neurophysiology of the cough reflex: ACCP evidence-based clinical practice guidelines. Chest 2006; 129(Suppl 1): 33-47S.
63. Canning BJ, Farmer DG, Mori N. Mechanistic studies of acid evoked coughing in anesthetized guinea pigs. Am J Physiol Regul Integr Comp Physiol 2006; 291(2): R454-63.
64. Canning BJ, Mazzone SB, Meeker SN, Mori N, Reynolds SM, Undem BJ. Identification of the tracheal and laryngeal afferent neurones mediating cough in anaesthetized guinea-pigs. J Physiol 2004; 557(Pt 2): 543-58.
65. Kollarik M, Undem BJ. Mechanisms of acid-induced activation of airway afferent nerve fibres in guinea-pig. J Physiol 2002; 543(Pt 2): 591-600.
66. Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol 1995; 79(4): 1082-7.
67. Mitchell JE, Campbell AP, New NE et al. Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 2005; 31(3): 295-306.
68. Groneberg DA, Niimi A, Dinh QT et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 2004; 170(12): 1276-80.
69. Krishtal O. The ASICs: signaling molecules? Modulators? Trends Neurosci 2003; 26(9): 477-83.
70. Choudry NB, Fuller RW. Sensitivity of the cough reflex in patients with chronic cough. Eur Respir J 1992; 5(3): 296-300.
71. Carr MJ, Lee LY. Plasticity of peripheral mechanisms of cough. Respir Physiol Neurobiol 2005; 152(3): 298-311.
72. Bonham AC, Sekizawa SI, Joad JP. Plasticity of central mechanisms for cough. Pulm Pharmacol Ther 2004; 17(6): 453-7 (discussion 469-70).
73. Carr MJ, Hunter DD, Jacoby DB, Undem BJ. Expression of tachykinins in non-nociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am J Respir Crit Care Med 2002; 165(8): 1071-5.
74. Piedimonte G, Hegele RG, Auais A. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr Res 2004; 55(4): 657-65.
75. Doherty MJ, Mister R, Pearson MG, Calverley PM. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 2000; 55(8): 643-9.
76. Choudry NB, Fuller RW, Pride NB. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis 1989; 140(1): 137-41.
77. Hargreaves M, Ravi K, Senaratne MP, Kappagoda CT. Responses of airway rapidly adapting receptors to bradykinin before and after administration of enalapril in rabbits. Clin Sci (Lond) 1992; 83(4): 399-407.
78. O'Connell F, Springall DR, Moradoghli-Haftvani A et al. Abnormal intraepithelial airway nerves in persistent unexplained cough? Am J Respir Crit Care Med 1995; 152(6 Pt 1): 2068-75.
79. Basoglu OK, Pelleg A, Essilfie-Quaye S, Brindicci C, Barnes PJ, Kharitonov SA. Effects of aerosolized adenosine 5′-triphosphate vs adenosine 5′-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 2005; 128(4): 1905-9.
80. Crummy F, Livingston M, Ardill JE, Adamson C, Ennis M, Heaney LG. Endobronchial adenosine monophosphate challenge causes tachykinin release in the human airway. J Allergy Clin Immunol 2005; 116(2): 312-7.
81. Dai Y, Moriyama T, Higashi T et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004; 24(18): 4293-9.
82. Gatti R, Andre E, Amadesi S et al. Protease-activated receptor-2 activation exaggerates TRPV1-mediated cough in guinea pigs. J Appl Physiol 2006; 101(2): 506-11.